Citigroup
BIVI icon

Citigroup’s BioVie BIVI Stock Holding History

Citigroup’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,164
Closed -$4.43K – 5747
2026
Q1 		$4.43K Buy
+3,164
New +$4.07K ﹤0.01% 5289
2025
Q3 		– Sell
-551
Closed -$5.1K – 6091
2025
Q2 		$5.1K Buy
+551
New +$5.44K ﹤0.01% 5277
2025
Q1 		– Hold
0
– -$4 – 5600
2024
Q4 		– Hold
0
– – – 5788
2024
Q3 		– Sell
-19
Closed -$606 – 5633
2024
Q2 		$757 Sell
19
-8
-30% -$383 ﹤0.01% 5393
2024
Q1 		$1.43K Buy
27
+7
+35% +$718 ﹤0.01% 5411
2023
Q4 		$2.54K Buy
+20
New +$6.01K ﹤0.01% 5402
2023
Q3 		– Sell
-10
Closed -$3.91K – 5431
2023
Q2 		$4.26K Sell
10
-16
-62% -$10.8K ﹤0.01% 5203
2023
Q1 		$20.7K Buy
26
+5
+24% +$3.31K ﹤0.01% 4502
2022
Q4 		$16.6K Buy
+21
New +$11.4K ﹤0.01% 4662
2021
Q2 		– Sell
-5
Closed -$9K – 6130
2021
Q1 		$9K Sell
5
-1
-17% -$2.85K ﹤0.01% 5678
2020
Q4 		$11K Buy
+6
New +$5.99K ﹤0.01% 6916

Other funds holding BIVI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Citigroup's BIVI Position: Q2 2026 in Review

Citigroup sold out of BioVie (BIVI) in Q2 2026, closing a stake of 3,164 shares — an estimated $4.43K sold.

Citigroup first reported a position in BIVI in Q4 2020 and held it in 10 quarters. The position peaked at $20.7K in Q1 2023. 36 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

  • Citigroup reported no remaining BioVie position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 3,164 BioVie shares in Q2 2026, an estimated $4.43K.
  • Citigroup first reported a position in BioVie in Q4 2020 and held it in 10 quarters.
  • Citigroup's BioVie position peaked at $20.7K in Q1 2023.
  • 36 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.